1. Sanofi's share capital totals €2.44 billion as of November 2025. 2. A total of 1,227,469,992 shares are issued by Sanofi. 3. Real voting rights exclude treasury shares totaling 1,345,585,094. 4. Theoretical voting rights, including treasury shares, reach 1,361,665,420. 5. Detailed information is accessible on Sanofi's investor website.
FAQ
Why Neutral?
While the data indicates share issuance, it lacks significant market implications. Historical data suggest minimal price fluctuation from such announcements.
How important is it?
The article provides standard corporate governance information, which generally does not influence stock prices.
Why No Impact?
Voting rights data does not impact immediate or future stock performance significantly, similar to previous disclosures.
Sanofi Reports Total Voting Rights and Shares as of November 2025
Sanofi (SNY), the prominent French pharmaceutical company, has released significant information regarding its total number of voting rights and shares. This disclosure complies with article L. 233-8 II of the French Commercial Code and article 223-16 of the General Regulation of the French stock market authority. The data, indicating the company's financial framework, was made available on 30 November 2025.
Key Figures on Shares and Voting Rights
As of the specified date, the total number of issued shares and voting rights for Sanofi is as follows:
- Total Shares Issued: 1,227,469,992
- Number of Real Voting Rights (excluding treasury shares): 1,345,585,094
- Theoretical Voting Rights (including treasury shares): 1,361,665,420
This information provides insight into Sanofi's share capital of €2,438,854,192 and its underlying voting structure, crucial for investors and stakeholders in understanding the company's governance.
Regulatory Compliance and Public Access
Sanofi ensures compliance with French financial regulations through its disclosures. The data provided adheres to the guidelines of Article 223-11 of the General Regulation of the French stock market authority. For ongoing updates and detailed information, stakeholders are encouraged to visit Sanofi's official website under the section for Regulated Information in France: Sanofi Share and Voting Rights.
About Sanofi (SNY)
Sanofi, registered at the Paris Commercial and Companies Registry under number 395 030 844, is headquartered at 46, avenue de la Grande Armée, 75017 Paris, France. The company continues to innovate in the healthcare sector, making significant strides in pharmaceuticals and biologics.